Sofinnova Investments, Inc. Q1 2024 Filing
Filed May 15, 2024
Portfolio Value
$1.8T
Holdings
69
Report Date
Q1 2024
Filing Type
13F-HR
All Holdings (69 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 1 | NTRANatera Inc | 1,550,280 | $141.8B | 7.90% | |
| 2 | VERAVera Therapeutics Inc | 2,793,987 | $120.5B | 6.71% | |
| 3 | ASNDAscendis Pharma A/S | 754,032 | $114.0B | 6.35% | |
| 4 | AVTEAerovate Therapeutics Inc | 3,758,686 | $111.1B | 6.19% | |
| 5 | MRKMerck & Co Inc | 651,299 | $85.9B | 4.79% | |
| 6 | XBISpdr Ser Tr | 850,000 | $80.7B | 4.49% | Put |
| 7 | NVONovo-Nordisk A S | 611,884 | $78.6B | 4.38% | |
| 8 | INCYIncyte Corp | 1,327,178 | $75.6B | 4.21% | |
| 9 | ARGXArgenx SE | 149,300 | $58.8B | 3.27% | |
| 10 | ISRGIntuitive Surgical Inc | 140,880 | $56.2B | 3.13% | |
| 11 | DYNDyne Therapeutics Inc | 1,936,650 | $55.0B | 3.06% | |
| 12 | INBXUSDInhibrx Inc | 1,302,645 | $45.5B | 2.54% | |
| 13 | ELANElanco Animal Health Inc | 2,555,547 | $41.6B | 2.32% | |
| 14 | IDXXIDEXX Labs Inc | 75,224 | $40.6B | 2.26% | |
| 15 | AZNAstraZeneca PLC | 596,713 | $40.4B | 2.25% | |
| 16 | SNDXSyndax Pharmaceuticals Inc | 1,608,540 | $38.3B | 2.13% | |
| 17 | PODDInsulet Corp | 220,203 | $37.7B | 2.10% | |
| 18 | YMABUSDY-mAbs Therapeutics Inc | 2,194,278 | $35.7B | 1.99% | |
| 19 | IDYAIDEAYA Biosciences Inc | 781,596 | $34.3B | 1.91% | |
| 20 | TCE2Celldex Therapeutics Inc | 801,777 | $33.7B | 1.87% | |
| 21 | INZYInozyme Pharma Inc | 4,280,308 | $32.8B | 1.83% | |
| 22 | AFWAlign Technology Inc | 95,478 | $31.3B | 1.74% | |
| 23 | AVBPArrivent Biopharma Inc | 1,696,752 | $30.3B | 1.69% | |
| 24 | TGTXTG Therapeutics Inc | 1,984,962 | $30.2B | 1.68% | |
| 25 | SRPTSarepta Therapeutics Inc | 227,488 | $29.5B | 1.64% | |
| 26 | MRNS*Marinus Pharmaceuticals Inc | 3,255,753 | $29.4B | 1.64% | Put |
| 27 | BSXBoston Scientific Corp | 353,851 | $24.2B | 1.35% | |
| 28 | IMTXImmatics NV | 2,163,646 | $22.7B | 1.27% | |
| 29 | SILKSilk Rd Med Inc | 1,189,024 | $21.8B | 1.21% | |
| 30 | COGTCogent Biosciences Inc | 2,400,771 | $16.1B | 0.90% | |
| 31 | EXASExact Sciences Corp | 229,481 | $15.8B | 0.88% | |
| 32 | ALNYAlnylam Pharmaceuticals Inc | 103,036 | $15.4B | 0.86% | |
| 33 | IMNMImmunome Inc | 594,396 | $14.7B | 0.82% | |
| 34 | PHVSPharvaris N V | 584,672 | $13.5B | 0.75% | |
| 35 | YB4PSavara Inc | 2,347,261 | $11.7B | 0.65% | |
| 36 | SWAVUSDShockwave Med Inc | 35,000 | $11.4B | 0.63% | |
| 37 | KURAKura Oncology Inc | 501,940 | $10.7B | 0.60% | |
| 38 | ROIVRoivant Sciences Ltd | 1,001,704 | $10.6B | 0.59% | |
| 39 | AXNX*Axonics Inc | 149,385 | $10.3B | 0.57% | |
| 40 | PEPGPepGen Inc | 503,624 | $7.4B | 0.41% | |
| 41 | CABACabaletta Bio Inc | 429,746 | $7.3B | 0.41% | |
| 42 | ESTAEstablishment Labs Hldgs Inc | 141,162 | $7.2B | 0.40% | |
| 43 | SP4PAchieve Life Sciences Inc | 1,518,230 | $6.9B | 0.38% | |
| 44 | SLNOSoleno Therapeutics Inc | 150,775 | $6.5B | 0.36% | |
| 45 | FDMT4D Molecular Therapeutics Inc | 198,186 | $6.3B | 0.35% | |
| 46 | NXTCNextcure Inc | 2,671,856 | $6.0B | 0.33% | |
| 47 | AVTRAvantor Inc | 232,446 | $5.9B | 0.33% | |
| 48 | MDGLMadrigal Pharmaceuticals Inc | 19,029 | $5.1B | 0.28% | |
| 49 | BOLT1EURBolt Biotherapeutics Inc | 2,754,437 | $3.9B | 0.21% | |
| 50 | —Fusion Pharmaceuticals Inc | 157,172 | $3.4B | 0.19% | |
| 51 | 3M4Masimo Corp | 20,000 | $2.9B | 0.16% | |
| 52 | TFXTeleflex Incorporated | 12,142 | $2.7B | 0.15% | |
| 53 | IM8NInsmed Inc | 100,000 | $2.7B | 0.15% | Call |
| 54 | COOCooper Cos Inc | 21,236 | $2.2B | 0.12% | |
| 55 | INSPInspire Med Sys Inc | 8,099 | $1.7B | 0.10% | |
| 56 | AMLXAmylyx Pharmaceuticals Inc | 606,729 | $1.7B | 0.10% | Put |
| 57 | LIVNLivaNova PLC | 20,456 | $1.1B | 0.06% | |
| 58 | —Nucana PLC | 3,400,739 | $884.2M | 0.05% | |
| 59 | BAXBaxter Intl Inc | 20,000 | $854.8M | 0.05% | |
| 60 | IMTXImmatics NV | 316,349 | $853.1M | 0.05% | |
| 61 | PDSBPDS Biotechnology Corp | 142,635 | $564.8M | 0.03% | |
| 62 | ISREURPerspective Therapeutics Inc | 430,105 | $511.8M | 0.03% | |
| 63 | NARIUSDInari Med Inc | 10,216 | $490.2M | 0.03% | |
| 64 | IRONDisc Medicine Inc | 6,173 | $384.3M | 0.02% | |
| 65 | GPCRStructure Therapeutics Inc | 8,733 | $374.3M | 0.02% | |
| 66 | —Nucana PLC | 1,307,875 | $340.0M | 0.02% | |
| 67 | KYTXKyverna Therapeutics Inc | 10,000 | $248.4M | 0.01% | |
| 68 | —Ikena Oncology Inc | 115,712 | $164.3M | 0.01% | |
| 69 | MIRMMirum Pharmaceuticals Inc | 3,012 | $75.7M | 0.00% |